Investor Presentation H1 2023

124 Investor presentation First six months of 2023 Obesity market share and market growth in EMEA 120% 100% 80% 60% 40% 20% Obesity market growth and Novo Nordisk market share 0% May 2020 -NN market share -NN Growth -Market growth (right axis) Source: IQVIA, May 2023, Value, MAT; EMEA: Europe, Middle East and Africa; NN: Novo Nordisk DKK billion Obesity market size and growth -81% 120% 3.2 0.1 99% 100% 86% 1.3 80% 81% 1.7 60% 40% 78% 20% EMEA -99% 86% 0% May May May 2023 2022 2023 Novo Nordisk Others

View entire presentation